STARD8 Antikörper
Kurzübersicht für STARD8 Antikörper (ABIN7119500)
Target
Alle STARD8 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Verwendungszweck
- STARD8 antibody
-
Aufreinigung
- Immunogen affinity purified
-
Reinheit
- ≥95 % as determined by SDS-PAGE
-
Immunogen
- StAR-related lipid transfer(START) domain containing 8
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- WB: 1:500-1:2000, IHC: 1:20-1:200
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide and 50 % glycerol pH 7.3,
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freeze / thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- -20°C for 12 months
-
Haltbarkeit
- 12 months
-
-
- STARD8 (StAR-Related Lipid Transfer (START) Domain Containing 8 (STARD8))
-
Andere Bezeichnung
- STARD8
-
Hintergrund
-
Synonyms: StAR-related lipid transfer protein 8|Deleted in liver cancer 3 protein (DLC-3)|START domain-containing protein 8 (StARD8)|START-GAP3|STARD8|DLC3|KIAA0189
Background: Accelerates GTPase activity of RHOA and CDC42, but not RAC1. Stimulates the hydrolysis of phosphatidylinositol 4,5-bisphosphate by PLCD1.
-
Molekulargewicht
- 115-120 kDa
-
Gen-ID
- 9754
-
UniProt
- Q92502
Target
-